Ilanah Pruis

Ilanah Pruis is a Researcher in the Department of Radiology & Nuclear Medicine at Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands, specializing in advanced neuroimaging techniques for brain tumor diagnosis and treatment. Her work integrates PET-MRI and molecular imaging modalities to address critical challenges in neuro-oncology.

Her research spans Neuroimaging, Oncology, and Nuclear Medicine with concentrated expertise in brain tumor imaging. Key specializations include [18F]FET PET/MRI for pituitary tumors, PSMA-targeted radioligand therapy, and reproducibility validation of novel MRI techniques like CEST-MRI. Her methodology emphasizes translational applications for improving diagnostic accuracy and therapeutic planning in neuro-oncology.

Analysis of her 2023-2024 publications reveals a cohesive research trajectory focused on theranostic PET-MRI applications for brain tumors. Dominant themes include molecular imaging of glioblastoma, intra-arterial radioligand delivery systems, and multi-scanner reproducibility standards for advanced MRI sequences. These studies consistently demonstrate multicenter collaboration patterns and prioritize clinical translation of imaging biomarkers for tumor characterization.

No scientific awards were documented in the available professional records.

Information regarding doctoral student supervision, grant funding history, or formal mentoring activities was not disclosed in the source materials.

Dr. Pruis operates within Erasmus MC's Radiology & Nuclear Medicine infrastructure, participating in neuro-oncology research teams focused on hybrid imaging validation. Her collaborative network extends to multicenter consortia investigating PSMA expression in glioblastoma and intra-arterial therapeutic delivery systems, as evidenced by her co-authorship in major inventory studies.